Vol. 91, No. 2, 1979 November
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
28, 1979
THE
Pages 490-497
INVOLVEMENT
OF
OF A NON-‘BAY-REGION’
BENZ(a)ANTHRACENE-DNA
A.D.
Chester
Received
ADDUCTS
MacNicoll, A.
Beatty Cancer
October
DIOL-EPOXIDE
C.S.
Hewer,
C.
Research Hospital,
IN A RAT-LIVER
Cooper,
0.
Walsh,
P.L.
Institute, Fulham
Road,
Ribeiro,
IN THE
FORMATION
MICROSOMAL
SYSTEM
P.G.
Grover
and
Institute London
Gervasi”,
P.
Sims
of Cancer SW3 6JB,
Research:Royal England
8, 1979
SUMMARY: The metabolic activation of benz(a)anthracene was investigated incubating [3H]-b enz(a)anthracene with DNA, a NADPH-generating system rat-liver microsomes. When hydrolysates of the DNA were chromatographed Sephadex LH20 columns, three hydrocarbon-nucleoside adduct peaks were resolved and these were further examined using HPLC. One adduct probably results from the reaction of the non-bay-region diol-epoxide r-8,t-9dihydroxy-t-l0,11-oxy-8,9,lO,ll-tetrahydrobenz(a)anthracene (%ti=BA-8,9diol lO,ll=oxide) with DNA. The other two adducts did not co-chromatograph with adducts formed from any of the four possible isomeric diolepoxides that can be formed in the 8,9,10,11-ring of benz(a)anthracene.
INTRODUCTION: biological may
and
systems
be
ation
further of
ic to
aromatic
metabolized
that to
hydrocarbon-nucleic
through with
the
nucleic
hydrocarbon
with
preparations adducts >: Present
(4,s) formed
address:
are
hydrocarbons
products
of
have
vicinal studies
nucleic
acids
in
shown
that
CNR,
to
Pisa,
those
shown
Studies
vivo
from
that
these
diol-epoxides
Other
similar
--in
that
the some
of
that
are
of the
in
several that
on
the
adducts the the
(1) probably
bay-region incubation
rat-liver
--in
type of
a
microsomal
hydrocarbon-nucleic formed
form-
benzo(a)pyrene
of
involved
presence
ized dihydrodiols
diol-epoxides.
acids.
have
metabol
non-K-region
adducts
(2) reaction
are
include
vicinal acid
7-methylbenz(a)anthracene
arise (3)
Polycycl
by and on
vivo
acid and
that
are
Italy
Abbreviations: Anti-BA-8,9-diol lO,ll-oxide, r-8,t-9-dihydroxy-t-lO,ll-oxy8,9,10,11-tetrahydrobenz(a)anthracene; z-BA=8,9=diol lO,ll-oxTde, r-8,t-9dihydroxy-~-10,11-oxy-8,9,10,11-tetrahydrobenz(a)anthracene; anti-BA~lO,ll-dial 8,9-oxide, t-10, I-ll-dihydroxy-t-8,9-oxy-8,9,1O,ll-tetrahydrobenz(a)anthracene; z-BA-lO,ll-diol 8,9-oxide, ~-l0,r-ll-dihydroxy-c-8,9-oxy-8,9,lO,ll-tetrahydrobenz(a)anthracene .
0006-291X/79/220490-08$01.00/0 Copyright All rights
@ I979 by Academic Press, Inc. of reproduction in anyform reserved.
490
Vol. 91, No. 2, 1979
BIOCHEMICAL
thought
to
be
involved
effects
of
the
parent
bay-region been
theory
obtained of
the
hydrocarbons.
shown
the
parent
found
with
that
the
that
this
ing
in
the
8,8,TO,ll-ring
not
of
the
bay-region
or
rats of
In
type. that
and
shown)
and
related
active
in
both
It
has
incubated
of
agreement
with
with
pretreated
hydrocarbon-DNA DNA
with
anti-BA-8,9-diol
in
the
mutagenic dihydrodiols
recently
been are
culture
the
formed
were
treated
spectrum
results adduct of
3-methylcholanthrene with
although
occurr-
diol-epoxide
presence
lO,ll-oxide
the
benz(a)anthracene
a vicinal this
systems from
fluorescence of
formation
vicinal
that
in
these
systems,
adducts
cells
activation
a major
these
(10)
embryo
of
derived
a phenanthrene-like
the
results
test
acid
hamster
(8,9)
in
carcinogenic.
metabolic by
is from
reaction
vivo
with
showing
benz(a)anthracene
the
weakly
the has
to
initiating
highly
of
tumourigenic
dihydrodiols
tumour
is
support
metabolized active
hydrocarbon-nucleic
--in
consistent
more
carcinogenic
hydrocarbons
and
further
other
the
The
(formula
possessed
evidence
are or
the
only
major
be
and
polycyclic (6,7)
may
type
on
is
skin
and
by
that
RESEARCH COMMUNICATIONS
in
hydrocarbons.
3,4-dihydrodiol
the
mouse
preparations
several
benz(a)anthracene
benz(a)anthracene
provide
of
of
mutagenic
hydrocarbons,
hydrocarbon
is
the
studies
of
either
on
of
evidence
activation
bay-region
parent
(11)
(12)
when
the
Thus,
activities
activation Further
dihydrodiols
of
either
metabolic
metabolic studies
that
diol-epoxides
have
of
dihydrodiols
show
than
the
hydrocarbon.
from
activities studies
in
AND BIOPHYSICAL
that presented
formed rat-liver probably
is here
when microsomal arises
DNA.
2
a
7
6
I MATERIALS AND METHODS: C3H]-Benz(a)anthracene unlabelled hydrocarbon by catalytic exchange Bucks, U.K.). The anti-BA-8,9-diol lO,ll-oxide
491
(1.5 Ci/mmol) was prepared from (Radiochemical Centre, Amersham, and the --BA-8,9-diol
Vol.
91,
lO,Tl-oxide 8,9-oxide Keith of Repository that was St. Louis,
No.
2, 1979
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
were synthesized as described (13,14) and the anti-BA-lO,ll-diol and the syn-BA-lO,ll-diol 8,9-oxide were kindly supplied by Dr.J.N. the I.I.T. Research Institute, Chicago, Ill., USA through the Chemical of the National Cancer Institute. DNA (salmon testes, type I II), deproteinized before use, was obtained from Sigma Chemical Co., MO., USA.
Chemical and enzymic reactions of benz(a)anthracene with DNA. Each of the four diol-epoxides of benz(a)anthracene named above were incubated with DNA and the DNA’ isolated and hydrolysed to nucleosides exactly as described previously (2). [3H]-B enz ( a ) ant h racene (2 pmol) was incubated at 37OC with DNA (125 mg), NADP, MgCl 2, glucose 6-phosphate and glucose 6-phosphate dehydrogenase in the presence of a microsomal fraction (2) prepared from 1 iver (209) from rats that had been pretreated with 3-methylcholanthrene. After 30 min, the incubation mixture was cooled to 4OC, the microsomes separated by centrifugation (1 h, 100,000 x g, 4’C) and DNA precipitated from the supernatant with ethanol (2 x 1 vol). The DNA was washed with ethanol, deproteinized and hydrolysed to nucleosides as described (2). Sephadex
LH20 column chromatography and high pressure liquid chromatoSamples of enzymic hydrolysates of DNA that had been incubated $$73 H ]- benz(a)anthracene in the presence of a rat-liver microsomal fraction were mixed with UV-absorbing amounts of nucleoside adducts obtained from the chemical reaction of one of four diol-epoxides of benz(a)anthracene with DNA and the mixture chrcmatographed on columns (70 x 1.5 cm) of Sephadex LH20 that were eluted with either water-methanol (15) or with sodium borate (O.O5M,pH 8.7)-methanol (16) gradients as described. Eluant fractions (5 ml) were collected and the absorbance (260 nm) and fluorescence (excitation 300 nm, emission 356 nm) determined for each fraction. 3H-Labelled products present in each fraction were determined by liquid scintillation counting of a sample (1 ml) of each fraction in PTX scintillant (10 ml) (Packard Instrument Co., Downers USA) using a Packard Tricarb 3320 scintillation counter. Grove, Illinois, MO., Fractions that contained hydrocarbon-nucleoside adducts that were to be further investigated were pooled and evaporated to dryness and the residue dissolved in methanol (0.5 ml). Samples (0.1 - 0.25 ml) of these solutions were examined by HPLC at 40°C on columns of Spherisorb 5 ODS (4 x 250 mm; HPLC Technology Ltd., Wilmslow, Cheshire, U.K.) that were eluted at a flow rate of 2 ml/min with a convex gradient, over 45 min, from O-35% methanol in water and then with a concave gradient, over 45 min, from 35-65% methanol in water using a Waters 660 Solvent Programmer (Waters Associates Ltd., Hartford, Cheshire, U.K.). Fractions (2 ml) of eluate were collected and hydrocarbon-nucleoside adducts detected by fluorescence as described above. Radiolabelled products in samples (1 ml) of each fraction were determined by liquid scintillation counting. In some cases, fractions from Sephadex LH20 evaporated to dryness and the residues incubated with co1 umns were pooled, acetic anhydride-pyridine (l:g, v/v; 0.5 ml, 40h at 4’C). The mixtures were evaporated to 100 ~1 volume with a stream of nitrogen and the residues examined by HPLC at 40°C on a column of Spherisorb 5 ODS that was eluted with a convex gradient, over 45 min, of O-60% methanol in water followed by a concave gradient over 45 min, of 60-80% methanol in water, at a flow rate of Fractions (2 ml) of eluant were collected and fluorescence and 2 ml/min. radioactivity determined as described above.
RESULTS
AND
DISCUSSION:
II 1
3 H -benz(a)anthracene
Sephadex
LH20
columns,
When
hydrolysates
and
a metabolizing
the
elution
of
DNA
system
profile
contained
492
that were
had
been
chromatographed three
peaks
incubated
with on
(products
BIOCHEMICAL
Vol. 91, No. 2, 1979
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
25
0
1
I 25
2.0
1 50
Fraction
1 75
I 100
number
I 125
I 150
2.0
1.5
1.5 3 zei 2 5
& g
1.0
1.0
0.5
0.5
4 !s “0 s 2s “2
w”
0 25
50
75 Fraction
Fig.
111,
Sephadex A hydrolysate fraction a hydrolysate lO,ll-oxide. gradient fig. 16)
IV
and
V
fig.
LH20
with
in
and
and and
1)
that
Sephadex
in and
The
be
formed
which
wi th
columns
or in
the
region
150
of of
hydrolysates
occupied
these DNA
benz(a)anthracene of
DNA
that
that
had
493
been
benz(a)anthracene.
invest-
incubated
had
been
on
incubated
8,g-oxide,
8,+oxide, of
was
co-chromatographed
anti-BA-lO,ll-diol
8,9.10,11-ring
by
products
were
-syn-BA-lO,ll-diol the
normally
identity
hydrolysates
lO,ll-oxide,
lO,ll-oxide can
in
abelled
3H-1
anti-BA-8,Pdiol
8,9-diol that
experiments
LHZO
either
eluted
adducts.
microsomes
125
column chromatography of hydrocarbon-nucleoside adducts. of DNA that had been incubated with a rat-liver microsomal 3H-labelled benz(a)anthracene was co-chronatographed with of DNA that had been incubated with anti-BA-8,9-diol The Sephadex LH20 column was eluted with a water-methanol radioactivity (D---O, fig. lA), fluorescence (A+, absorbance (m, fig. 1B) were determined.
hydrocarbon-nucleoside igated
100 number
the
four
with ~JJ-BA-
diol-epoxides When
the
Vol. 91, No. 2, 1979
Sephadex
LH20
labelled
product
nucleoside
columns
were did
V
adducts
labelled
products
8,9-diol
lO,ll-oxide
diol-epoxides identity
in
which
not
formed III
and
products
3H-labelled
water-methanol
with these
did 1)
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
with
co-elute
IV
not
of
eluted
from
(fig. (results
The ments
BIOCHEMICAL
and
any
four
the
with
hydrocarbon-
However,
adducts
adducts
jH-
non-labelled
diol-epoxides.
co-elute with
of
gradients,
formed
formed from
3H-
from the
anti-BA-
other
three
shown). III
and
products
was
IV
and
further
investigated
non-labelled
adducts
in that
experi-
co-eluted
0
10
Fig.
2
20
30
40 Fraction
50 number
Fraction
number
60
70
80
High pressure 1 iquid chromatography of deoxyribonucleoside-hydrocarbon adducts. 3H-Labelled products present in the hydrolysis of DNA that had been incubated with[sH)benz(a)anthracene in the presence of a rat-liver microsomal fraction and fluorescent amounts of non-labelled adducts formed from DNA that had been incubated with anti-BA-8,9diol lO,ll-oxide in vitro were co-chromatographed on Sephadex LH20 Eluted fractions Gnmng 9H-labelled product III and non-labelled product VI(fractions 74-90, fig. 1A.B) were pooled and subjected to HPLC on Spherisorb 9 ODS either before (fig. 2A) or after (fig. 28) acetylation. Eluted fractions were examined for the presence of fluorescent and radioactive material.
494
Vol. 91, No. 2, 1979
from
Sephadex
BIOCHEMICAL
LH20
were
3 H-labelled
system,
In
3 H-label
w-BA-lO,ll-diol (fig.
co-eluted Spherisorb
with
from
adducts
oxide
and
from
Under
formed
several
fractions
used
separated
these in
HPLC
III
were
on
was
separated
syn-BA-8,9-diol
of
with
a similar
position
to
the
position
that
of
the
is
not
lO,ll-
formed
non-labelled
from
8,9-oxide
was
nucleoside-hydrocarbon
adducts
However,
III
syn-BA-lO,ll-diol
the
in
this
study
the
been
suggest
or
conditions,
V are
has
ites
product
product
borate
and
Sephadex
with
to
that
lO,ll-oxide
8,9-oxide,
sodium
IV
by
and
adducts
prior
28);
lO,ll-
adducts
(0.05
M,
formed that of
pH 8.7)-methanol
from
in
which
elution
products
on
the
two
they of
and,in
syn-
eluted
in
product
III
borate,eluted
earlier.
from
non-polar
(fig.
from
z-BA-8,9-diol
anti-BA-8,9-diol
3H-1abe11ed
eluted
to
Products
III
formed anti-BA-8,9-diol
non-labelled
acetylated
from
diol-epoxides.
from
and
this
separated
adducts
formed
and
from
behaviour
gradients. relative
four
from
adducts
anti-BA-lO,ll-diol
the
eluted
changed
the
of
separated
were
lO,ll-oxide
water-methanol
was
8,9-oxide
columns
that
columns
diol-epoxides
and
Using
8,9-oxide.
examining
gradients.
5 ODS.
than
products
RESEARCH COMMUNICATIONS
Spherisorb
each
from
product
x-BA-8,9-dial
LH20
on
was
not
adducts
evidence
Sephadex
study
LH20
z-BA-lO,ll-diol
by
III
3 H-labelled
only
formed
obtained
metabol
from
3H-labelled
Additional
epoxide
formed
but
Sephadex
5 ODS,
co-eluted
attempt
earlier
product
HPLC
anti-BA-lO,ll-diol
when
from
or
eluted
led
2A),
However,
oxide.
HPLC
IV
8,g-oxide
lO,ll-oxide
epoxides
by
adducts
addition,
either
examined
product
nucleoside-hydrocarbon
AND BIOPHYSICAL
may DNA,
with that
probably because
non-labelled LH20 made
the
3 H-labelled
adducts
identify
arisen has
been
DNA
in
a similar III
(data
the
IV
reaction
observed
is
from
the
system
(4).
formed
from
495
from
of
these
not
shown).
and
V,
of
for
any
products
formed
products by
as
product
formed
chromatography
to
have
not
results
anti-BA-8,g-diol
IV
diol-
and
V were by
Although
a K-region
The
four
diol-epoxides
product
reaction
the
V is or
of
no
further
relatively
other
simple
benzo(a)pyrene presented lO,ll-oxide
in
this
Vol. 91, No. 2, 1979
because
BIOCHEMICAL
a hydrocarbon-nucleoside
indistinguishable after
from
acetylation,
consistent formed
in
graphic
the
finding
mouse
skin
and
fluorescence
region the
spectra
activity
that in
of
of
bay-region
dihydrodiols
initiation
studies
LH20
column
major embryo
those
of
and
diol-epoxides
by
HPLC,
which
III
possess
indicate
might and
diol-epoxide both
was
before
chromatography.
and
do
benz(a)anthracene
this
cells
findings
that
RESEARCH COMMUNICATIONS
the in
not
is
adduct have
chromato-
phenanthrene-like
that
major
routes
necessarily
explain
the
high
activity
mutagenesis
and
This
benz(a)anthracene-DNA
peak
benz(a)anthracene
a suggestion
from
examined
the
These
formed
when
hamster to
(12).
activation
III
Sephadex
similar
diol-epoxide, low
by
with
properties
metabolic
adduct product
and
AND BIOPHYSICAL
involve discrepancy of (11)
the and
of a baybetween related
tumour
(10).
ACKNOWLEDGEMENTS The authors thank Mr. C.J. Cadwallader for technical assistance. This research was supported in part by grants to the Chester Beatty Research Institute, Institute of Cancer Research:Royal Cancer Hospital, from the Medical Research Council and the Cancer Research Campaign, and in part by grant CA21959 from the National Cancer Institute, USPHS. REFERENCES 1.
2. 3. 4. 5. 6. 7. 8. 9. 10
11.
Sims, P., Grover, P.L., Swaisland, A., Pal, K. and Hewer, A. (1974) Nature 252, 326-328 Tierney, B., Hewer, A., Walsh, C., Grover, P.L. and Sims, P. (1977) Chem.-Biol.lnteractions 9, 179-153 Jerina, D.M. and Daly, J.W. Oxidation at Carbon. In D.V. Parke and R.L. Smith (eds), Drug Metabolism, from Microbe to Man, Taylor E Francis Ltd., London (1977) pp 13-32 King, H.W.S., Thompson, M.H. and Brookes, P. (1975) Cancer Res. 35, 1263-1269 Thompson, M.H., King, H.W.S., Osborne, M.R. and Brookes, P. (1976) Int.J;Cancer ‘7, 270-274 Malaveille, C., Bartsch, H., Tierney, B., Grover, P.L. and Sims, P. (1978) Biochem.Biophys.Res.Commun. 83, 1468-1473 Wood, A.W., Levin, W., Ryan, D., Thomas, P.E., Yagi, H., Mah, H.D., Thakker, D.R., Jerina, D.M. and Conney, A.H. (1977) Biochem.Biophys.Res.Commun. 2, 847-854 Chouroul inkov, I., Gentil, A., Tierney, B., Grover, P.L. and Sims, P. (1977) Cancer Lett. 3, 247-253 Chouroulinkov, I., Gentil, A., Grover, P.L. and Sims, P. (1876) Br.J.Cancer 2, 523-532 Wood, A.W., Levin, W., Chang, R.L., Lehr, R.E., Schaefer-Ridder, M., Karle, J.M., Jerina, D.M. and Conney, A.H. (1977) Proc.Natl.Acad.Sci.USA 2, 3176-3179 Ertsch,H., Malaveil le, C., Tierney, B., Grover, P.L. and Sims, P. (1979) Chem.-Biol. interactions 26, 185-186
Vol. 91, No. 2, 1979
12.
13. 14.
16.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Vigny, P., Kindts, M., Duquesne, M., Cooper, Sims, P. (1979) (submitted for publication) Lehr, R.E., Schaefer-Ridder, M. and Jerina, Tetrahedron Lett. pp 539-542 Lehr, R.E., Schaefer-Ridder, M. and Jerina,
42, 15.
BIOCHEMICAL
C.S.,
Grover,
D.M.
(1977)
D.M.
(1977)
P.L.
and
J.Org.Chem.
736-744
Gird, (1973) King,
(1976)
W.M., Dipple, A., Grover, P.L., Sims, P. and Brookes, Cancer Res. 22, 2386-2392 H.W.S., Osborne, M.R., Beland, F.A., Harvey, R.G. and Proc.Natl.Acad.Sci.USA 2, 2679-2681
497
P. Brookes,
P.